CJ
NVAX icon

Caitlin John’s Novavax NVAX Stock Holding History

Caitlin John’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204 Hold
25
– – ﹤0.01% 896
2025
Q4 		$168 Hold
25
– – ﹤0.01% 898
2025
Q3 		$217 Buy
+25
New +$195 ﹤0.01% 844
2025
Q1 		– Sell
-25
Closed -$201 – 573
2024
Q4 		$201 Hold
25
– – ﹤0.01% 818
2024
Q3 		$194 Hold
25
– – ﹤0.01% 807
2024
Q2 		$317 Hold
25
– – ﹤0.01% 793
2024
Q1 		$120 Hold
25
– – ﹤0.01% 855
2023
Q4 		$120 Buy
+25
New +$153 ﹤0.01% 864

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitlin John's NVAX Position: Q1 2026 in Review

Caitlin John held its Novavax (NVAX) position steady in Q1 2026 at 25 shares worth $204. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Caitlin John first reported a position in NVAX in Q4 2023 and has held it in 8 quarters since. The position peaked at $317 in Q2 2024. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Caitlin John held 25 shares of Novavax worth $204 as of Q1 2026.
  • Caitlin John left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #896 holding.
  • Caitlin John first reported a position in Novavax in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Novavax position peaked at $317 in Q2 2024.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.